BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 23392403)

  • 1. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.
    Berois N; De Cremoux P; Mazal D; Sica A; Cedeira M; Caserta B; Barrios E; Osinaga E; Sastre-Garau X
    Int J Gynecol Cancer; 2013 Mar; 23(3):527-32. PubMed ID: 23392403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
    Pista A; de Oliveira CF; Lopes C; Cunha MJ;
    Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
    Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
    Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.
    Suthipintawong C; Siriaunkgul S; Tungsinmunkong K; Pientong C; Ekalaksananan T; Karalak A; Kleebkaow P; Vinyuvat S; Triratanachat S; Khunamornpong S; Chongsuwanich T
    Asian Pac J Cancer Prev; 2011; 12(4):853-6. PubMed ID: 21790214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study.
    Wu EQ; Liu B; Cui JF; Chen W; Wang JB; Lu L; Niyazi M; Zhao C; Ren SD; Li CQ; Gong XZ; Smith JS; Belinson JL; Liaw KL; Velicer C; Qiao YL
    Cancer Causes Control; 2013 Apr; 24(4):795-803. PubMed ID: 23397310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papilloma Virus Genotype Distribution in Cervical lesions in Zanjan, Iran.
    Ahmadi S; Goudarzi H; Jalilvand A; Esmaeilzadeh A
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3373-3377. PubMed ID: 29286606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
    Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
    Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
    Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
    Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
    J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue.
    Siriaunkgul S; Suwiwat S; Settakorn J; Khunamornpong S; Tungsinmunkong K; Boonthum A; Chaisuksunt V; Lekawanvijit S; Srisomboon J; Thorner PS
    Gynecol Oncol; 2008 Mar; 108(3):555-60. PubMed ID: 18199473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and distribution of high-risk human papillomavirus in Greece.
    Agorastos T; Lambropoulos AF; Sotiriadis A; Mikos T; Togaridou E; Emmanouilides CJ
    Eur J Cancer Prev; 2009 Nov; 18(6):504-9. PubMed ID: 19741545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.
    Clifford GM; Rana RK; Franceschi S; Smith JS; Gough G; Pimenta JM
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1157-64. PubMed ID: 15894666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
    Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
    BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.
    Diop-Ndiaye H; Sastre-Garau X; Drame A; Dembele B; Ba NN; Diop-Diongue O; Mbow M; Diakhaby MEB; Woto-Gaye G; Toure Kane C; Diop M
    J Med Virol; 2021 Aug; 93(8):5110-5117. PubMed ID: 33851737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype distribution of human papillomavirus in women with abnormal cervical cytology in an esophageal carcinoma high incidence area of China.
    Mai RQ; Huang B; Shen L; Zhang GH; Hong LL; Cai YM
    Asian Pac J Cancer Prev; 2014; 15(12):4945-50. PubMed ID: 24998569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
    Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
    PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.